Results 161 to 170 of about 293,751 (369)
Acta Dermato-Venereologicais missing (Short communication)
Takemichi Fukasawa +4 more
doaj +1 more source
The Journal of Clinical Pharmacology, EarlyView.Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley +1 more source
Journal of Periodontology, EarlyView.Abstract Background Periodontitis has been linked to various systemic health conditions. This study investigated whether the association between periodontitis and prostate‐specific antigen (PSA) is direct or mediated through intermediary systemic diseases.
Muhammad H. A. Saleh +7 more
wiley +1 more source
Skin Disease Detection and Classification of Actinic Keratosis and Psoriasis Utilizing Deep Transfer Learning [PDF]
arXivSkin diseases can arise from infections, allergies, genetic factors, autoimmune disorders, hormonal imbalances, or environmental triggers such as sun damage and pollution. Some skin diseases, such as Actinic Keratosis and Psoriasis, can be fatal if not treated in time. Early identification is crucial, but the diagnostic methods for these conditions are
arxiv
THE TREATMENT OF PSORIASIS BY ARSENIC IN LARGE DOSES. [PDF]
, 1878 Lewis Shapter
openalex +1 more source
Genital Crohn's disease in pediatrics and genetic associations
JPGN Reports, EarlyView.Abstract Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co‐occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote ...
Erica Chang +5 more
wiley +1 more source
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]
, 2019 Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M +4 more
core
Ecotoxicology and Environmental SafetyAcrylamide (AA), a hazardous chemical prevalent in the environment and human diet, and its metabolite glycidamide (GA) are suspected contributors to psoriasis.
Rui Ma +7 more
doaj